DECISION OF THE EEA JOINT COMMITTEE No 151/2019

of 14 June 2019

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2022/2143]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1)

Commission Delegated Regulation (EU) 2018/729 of 26 February 2018 amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of certain drug precursors in the list of scheduled substances (1) is to be incorporated into the EEA Agreement.

(2)	Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indent is added in point 15x (Regulation (EC) No 273/2004 of the European Parliament and of the Council) of Chapter XIII of Annex II to the EEA Agreement:

‘-	32018 R 0729: Commission Delegated Regulation (EU) 2018/729 of 26 February 2018 (OJ L 123, 18.5.2018, p. 4).’

Article 2

The text of Delegated Regulation (EU) 2018/729 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 15 June 2019, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 14 June 2019.

For the EEA Joint Committee

The President

Claude MAERTEN

(1) OJ L 123, 18.5.2018, p. 4.

(*) No constitutional requirements indicated.